Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Inventory (2020 - 2026)

Journey Medical filings provide 6 years of Inventory readings, the most recent being $10.6 million for Q4 2025.

  • On a quarterly basis, Inventory fell 28.93% to $10.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $10.6 million, a 28.93% decrease, with the full-year FY2025 number at $10.6 million, down 28.93% from a year prior.
  • Inventory hit $10.6 million in Q4 2025 for Journey Medical, down from $11.8 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $16.1 million in Q1 2022 to a low of $9.7 million in Q2 2024.
  • Median Inventory over the past 5 years was $12.6 million (2024), compared with a mean of $12.7 million.
  • Biggest five-year swings in Inventory: surged 602.42% in 2021 and later dropped 28.93% in 2025.
  • Journey Medical's Inventory stood at $9.9 million in 2021, then surged by 47.92% to $14.6 million in 2022, then decreased by 27.95% to $10.5 million in 2023, then soared by 42.17% to $14.9 million in 2024, then dropped by 28.93% to $10.6 million in 2025.
  • The last three reported values for Inventory were $10.6 million (Q4 2025), $11.8 million (Q3 2025), and $12.9 million (Q2 2025) per Business Quant data.